BioNano Genomics, Inc. (NASDAQ: BNGO) reported Q4 EPS of $, $0.10 better than the analyst estimate of ($0.10). Revenue for the quarter came in at $8.2 million versus the consensus estimate of $7.99 million.

For earnings history and earnings-related data on BioNano Genomics, Inc. (BNGO) click here.